Procalcitonin in Diagnosis of Bacterial Infections in Young Infants

B

Belfast Health and Social Care Trust

Status

Completed

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT03509727
PCT

Details and patient eligibility

About

A diagnostic accuracy study investigating the accuracy of procalcitonin in diagnosing invasive bacterial infections in your infants.

Full description

The primary aim of this study was to report on the diagnostic accuracy of procalcitonin in the diagnosis of bacterial infections in young infants. This included invasive bacterial infections; defined as the isolation of a bacterial pathogen in blood or cerebrospinal fluid culture. We conducted a prospective observational diagnostic accuracy study. Young infants less than 90 days of age presenting to the Royal Belfast Hospital for Sick Children with signs of possible bacterial infection were eligible for inclusion. Eligible infants underwent procalcitonin testing using 0.5ml of whole blood with a BRAHMS assay on the Samsung LABGEO IB10® analyser.

Enrollment

126 patients

Sex

All

Ages

Under 90 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected bacterial infection

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems